Effects of Human Papillomavirus Type 16 E7 Protein on the Growth of Cervical Carcinoma Cells and Immuno-Escape Through the TGF-β1 Signaling Pathway

Q Xu,SX Wang,L Xi,SF Wu,G Chen,Y Zhao,Y Wu,D Ma
DOI: https://doi.org/10.1016/j.ygyno.2005.09.051
IF: 5.304
2006-01-01
Gynecologic Oncology
Abstract:Objective. E7 is regarded as one of the main oncoproteins of high-risk human papillomaviruses (HPVs). It may affect the transforming growth factor beta 1 (TGF-beta 1) signaling pathway. In this study, the relationship between HPV-16 infection and the functions of three critical factors of the TGF-beta 1/Smads pathway was explored to assess the possible role of E7 in the development of cervical cancer.Methods. The expression of E7, TGF-beta 1, T beta R-II and Smad4 was detected by immunohistochemistry in paraffin-embedded cervical samples, and by RT-PCR and Western blotting in cervical cancer cell lines. The effect of TGF-beta 1 on the growth of cervical cancer cells were tested by methyl thiazolyl tetrazolium (MTT), and the effects of HPV-16 E7 protein on normal and malignant cervical cells were investigated by flow cytometry.Results. During the progression from benign to malignant lesions, the expression levels of TGF-beta 1 and Smad4 increased significantly in cervical carcinoma tissues. The expression of TGF-beta 1 was positively correlated with E7 expression. In vitro experiments showed that TGF-beta 1 could not inhibit the proliferation of several cervical carcinoma cell lines in long-term regulation, but could inhibit immunologic reactions of peripheral blood mononuclear cells (PBMCs). Blocking E7 expression could lower the expression level of TGF-beta 1 and induce cells to enter apoptosis.Conclusions. Our data indicate that HPV-16 E7 protein plays an important role during the development of cervical cancer by immunoinhibition and stimulation of tumor cell proliferation through the TGF-beta 1/Smads signaling pathway. (C) 2005 Elsevier Inc. All rights reserved.
What problem does this paper attempt to address?